Sm\u011bs CagriTirz kombinuje:<\/p>\n
Nam\u00edsto toho, aby p\u0159edstavoval nov\u00fd peptid, CagriTirz kombinuje dv\u011b zkouman\u00e9 metabolick\u00e9 slou\u010deniny s dopl\u0148kov\u00e9 mechanismy<\/strong>.Tirzepatid je du\u00e1ln\u00ed agonist\u00e9 receptor\u016f pro GLP-1\/GIP<\/strong>, zat\u00edmco Cagrilintide je dlouhodob\u011b p\u016fsob\u00edc\u00ed analog amylinu<\/strong>. Spole\u010dn\u011b umo\u017e\u0148uj\u00ed v\u00fdzkumn\u00edk\u016fm zkoumat t\u0159i hlavn\u00ed hormon\u00e1ln\u00ed dr\u00e1hy, kter\u00e9 se pod\u00edlej\u00ed na regulaci chuti k j\u00eddlu, sytosti a metabolick\u00e9 homeost\u00e1ze.<\/p>\n Chcete si v Evrop\u011b zakoupit sm\u011bs CagriTirz Blend? Spole\u010dnost Life Peptide dod\u00e1v\u00e1 vysoce \u010distou sm\u011bs CagriTirz Blend pro laboratorn\u00ed v\u00fdzkum a zaji\u0161\u0165uje spolehlivou dopravu po cel\u00e9 EU.<\/em><\/p>\n Sou\u010dasn\u00fd v\u00fdzkum obezity se st\u00e1le v\u00edce zam\u011b\u0159uje na l\u00e9\u010debn\u00e9 postupy, kter\u00e9 c\u00edl\u00ed na n\u011bkolik hormon\u00e1ln\u00edch drah sou\u010dasn\u011b<\/strong>.<\/p>\n Slo\u017eky p\u0159\u00edpravku CagriTirz p\u016fsob\u00ed prost\u0159ednictv\u00edm r\u016fzn\u00fdch biologick\u00fdch mechanism\u016f.<\/p>\n Tirzepatid<\/strong><\/a><\/p>\n Kagrilintid<\/strong><\/a><\/p>\n Spole\u010dn\u011b p\u0159edstavuj\u00ed t\u0159i vz\u00e1jemn\u011b se dopl\u0148uj\u00edc\u00ed endokrinn\u00ed dr\u00e1hy, kter\u00e9 reguluj\u00ed p\u0159\u00edjem potravy a energetickou rovnov\u00e1hu<\/strong>.<\/p>\n Na rozd\u00edl od n\u011bkter\u00fdch experiment\u00e1ln\u00edch sm\u011bs\u00ed m\u00e1 tato kombinace ji\u017e povzbudiv\u00e9 \u00fadaje z p\u0159edklinick\u00fdch studi\u00ed kombinovan\u00e9 l\u00e9\u010dby<\/strong>, a\u010dkoli zat\u00edm nejsou k dispozici \u017e\u00e1dn\u00e9 specifick\u00e9 klinick\u00e9 studie u lid\u00ed zam\u011b\u0159en\u00e9 p\u0159\u00edmo na tuto formulaci.<\/p>\n Tirzepatid (10 mg)<\/strong><\/p>\n Dvojit\u00fd agonista receptor\u016f GLP-1\/GIP, kter\u00fd byl d\u016fkladn\u011b zkoum\u00e1n v r\u00e1mci v\u00fdzkumu obezity a metabolismu. Klinick\u00e9 studie potvrdily, \u017ee tirzepatid pat\u0159\u00ed mezi nejd\u016fle\u017eit\u011bj\u0161\u00ed inkretinov\u00e9 peptidy nov\u00e9 generace pro regulaci t\u011blesn\u00e9 hmotnosti a kontrolu glyk\u00e9mie.<\/p>\n Cagrilintid (5 mg)<\/strong><\/p>\n Dlouhodob\u011b p\u016fsob\u00edc\u00ed analog amylinu, kter\u00fd je p\u0159edm\u011btem v\u00fdzkumu v oblasti regulace chuti k j\u00eddlu, signalizace sytosti a vyprazd\u0148ov\u00e1n\u00ed \u017ealudku. Jeliko\u017e p\u016fsob\u00ed nez\u00e1visle na inkretinov\u00fdch receptorech, dopl\u0148uje biologick\u00e9 \u00fa\u010dinky GLP-1\/GIP, nam\u00edsto aby je kop\u00edroval.<\/p>\n Jedn\u00edm z hlavn\u00edch c\u00edl\u016f v\u00fdzkumu metabolismu je aktivovat r\u016fzn\u00e9 hormon\u00e1ln\u00ed syst\u00e9my, kter\u00e9 reguluj\u00ed p\u0159\u00edjem potravy<\/strong>e.<\/p>\n C\u00edle tirzepatidu Receptory GLP-1 a GIP.<\/strong><\/p>\n Cagrilintide se zam\u011b\u0159uje na amylinov\u00e9 receptory<\/strong>.<\/p>\n D\u00edky tomuto komplement\u00e1rn\u00edmu profilu receptor\u016f se tato kombinace st\u00e1v\u00e1 v experiment\u00e1ln\u00edm metabolick\u00e9m v\u00fdzkumu st\u00e1le atraktivn\u011bj\u0161\u00ed. Ned\u00e1vn\u00e9 p\u0159edklinick\u00e9 studie uv\u00e1d\u011bj\u00ed, \u017ee v\u00fdrazn\u011bj\u0161\u00ed sn\u00ed\u017een\u00ed p\u0159\u00edjmu potravy a t\u011blesn\u00e9 hmotnosti ne\u017e u kter\u00e9hokoli z t\u011bchto peptid\u016f samostatn\u011b<\/strong>, co\u017e podporuje dal\u0161\u00ed zkoum\u00e1n\u00ed t\u00e9to kombinace. Tyto v\u00fdsledky je t\u0159eba vykl\u00e1dat jako v\u00fdsledky v\u00fdzkumu v ran\u00e9 f\u00e1zi, nikoli jako d\u016fkaz klinick\u00e9 \u00fa\u010dinnosti t\u00e9to sm\u011bsi.<\/p>\n V sou\u010dasn\u00e9 dob\u011b neprob\u00edhaj\u00ed \u017e\u00e1dn\u00e9 rozs\u00e1hl\u00e9 klinick\u00e9 studie f\u00e1ze II ani f\u00e1ze III, kter\u00e9 by hodnotily kompletn\u00ed p\u0159\u00edpravek CagriTirz.<\/p>\n Toto v\u011bdeck\u00e9 zd\u016fvodn\u011bn\u00ed v\u0161ak podporuj\u00ed:<\/p>\n Podle toho by m\u011bl b\u00fdt CagriTirz vn\u00edm\u00e1n sp\u00ed\u0161e jako v\u00fdzkumn\u00e1 formulace vytvo\u0159en\u00e1 z jednotliv\u011b zkouman\u00fdch peptid\u016f s nar\u016fstaj\u00edc\u00edmi d\u016fkazy o kombinaci ne\u017e jako klinicky ov\u011b\u0159en\u00e1 sm\u011bs.<\/p>\n CagriTirz<\/strong><\/p>\n \u00c7a\u011fr\u0131 Sema<\/strong><\/a><\/p>\n CagriReta<\/strong><\/a><\/p>\n CagriTirz zauj\u00edm\u00e1 st\u0159edn\u00ed pozici v tomto spektru, nebo\u0165 kombinuje dvoj\u00ed p\u016fsoben\u00ed inkretin\u016f se sign\u00e1ln\u00ed cestou amylinu a z\u00e1rove\u0148 se vyh\u00fdb\u00e1 agonismu glukagonov\u00e9ho receptoru.<\/p>\n Zve\u0159ejn\u011bn\u00e9 bezpe\u010dnostn\u00ed informace t\u00fdkaj\u00edc\u00ed se p\u0159\u00edpravku CagriTirz vych\u00e1zej\u00ed ze studi\u00ed, v nich\u017e byly jednotliv\u011b zkoum\u00e1ny l\u00e1tky cagrilintid a tirzepatid.<\/p>\n Oba peptidy byly spojov\u00e1ny p\u0159edev\u0161\u00edm s ne\u017e\u00e1douc\u00edmi \u00fa\u010dinky na za\u017e\u00edvac\u00ed trakt, jako jsou nevolnost, zvracen\u00ed, pr\u016fjem a sn\u00ed\u017een\u00e1 chu\u0165 k j\u00eddlu b\u011bhem zvy\u0161ov\u00e1n\u00ed d\u00e1vky<\/strong>. Vzhledem k tomu, \u017ee dosud nejsou k dispozici specializovan\u00e9 klinick\u00e9 studie kombinovan\u00e9ho p\u0159\u00edpravku, sou\u010dasn\u00e9 poznatky o bezpe\u010dnosti by m\u011bly vych\u00e1zet z d\u016fkaz\u016f pro ka\u017edou slo\u017eku zvl\u00e1\u0161\u0165.<\/p>\n Aplikace: laboratorn\u00ed a analytick\u00fd v\u00fdzkum \u00dalo\u017ei\u0161t\u011b<\/strong>Neotev\u0159en\u00e9 lyofilizovan\u00e9 lahvi\u010dky jsou nejl\u00e9pe skladov\u00e1ny chlazen\u00e9 p\u0159i 2\u20138 \u00b0C<\/strong>, co\u017e je metoda skladov\u00e1n\u00ed potvrzen\u00e1 na\u0161\u00edm v\u00fdrobn\u00edm partnerem a vhodn\u00e1 a\u017e po dobu 24 m\u011bs\u00edc\u016f. Preferuje se chlazen\u00ed, proto\u017ee minimalizuje zbyte\u010dn\u00e9 cykly zmrazov\u00e1n\u00ed a rozmrazov\u00e1n\u00ed b\u011bhem b\u011b\u017en\u00e9 manipulace. Pokud je vy\u017eadov\u00e1no podstatn\u011b del\u0161\u00ed skladov\u00e1n\u00ed, lze zmrazen\u00e9 uchov\u00e1vat i neotev\u0159en\u00e9 lyofilizovan\u00e9 lahvi\u010dky. Po rekonstituci v\u017edy skladujte p\u0159i 2\u20138 \u00b0C a nezmrazujte.<\/p>\n CagriTirz je dod\u00e1v\u00e1n jako lyofilizovan\u00e1 lahvi\u010dka a m\u011blo by s n\u00edm b\u00fdt zach\u00e1zeno za pou\u017eit\u00ed standardn\u00edch postup\u016f rekonstituce peptid\u016f vhodn\u00fdch pro v\u00fdzkumn\u00e9 prost\u0159ed\u00ed. Mus\u00ed b\u00fdt rekonstituov\u00e1n pomoc\u00ed bakteriostatick\u00e1 voda<\/a> p\u0159ed pou\u017eit\u00edm. Pro zachov\u00e1n\u00ed struktur\u00e1ln\u00ed integrity p\u0159idejte zvolen\u00e9 rozpou\u0161t\u011bdlo pomalu po vnit\u0159n\u00ed st\u011bn\u011b lahvi\u010dky nam\u00edsto p\u0159\u00edmo na peptidov\u00fd pr\u00e1\u0161ek a vyhn\u011bte se prudk\u00e9mu prot\u0159ep\u00e1v\u00e1n\u00ed. Jemn\u00e9 krou\u017een\u00ed je obecn\u011b dosta\u010duj\u00edc\u00ed, jakmile se peptid zcela rozpust\u00ed. Standardn\u00ed laboratorn\u00ed postupy zahrnuj\u00ed tak\u00e9 ponech\u00e1n\u00ed chlazen\u00fdch lahvi\u010dek dos\u00e1hnout pokojov\u00e9 teploty p\u0159ed rekonstituc\u00ed, aby se minimalizovala kondenzace uvnit\u0159 lahvi\u010dky.<\/p>\n Pro dal\u0161\u00ed pokyny k v\u00fdb\u011bru rozpou\u0161t\u011bdla, pl\u00e1nov\u00e1n\u00ed koncentrac\u00ed a skladov\u00e1n\u00ed viz \u00fapln\u00e9 Pr\u016fvodce rekonstituc\u00ed peptid\u016f<\/a> a Kalkula\u010dka rekonstituce<\/a>.<\/p>\n Pelomenn\u00e1 klinick\u00e1 studie f\u00e1ze II, kter\u00e1 etabluje cagrilintid jako p\u0159edn\u00ed dlouhodob\u00fd analog amylinu.<\/p>\n Kl\u00ed\u010dov\u00e1 klinick\u00e1 studie III. f\u00e1ze SURMOUNT-1, kter\u00e1 estabeleje tirzepatid jako jednu z p\u0159edn\u00edch du\u00e1ln\u00edch inkretinov\u00fdch terapi\u00ed pro v\u00fdzkum obezity.<\/p>\n Preklinick\u00fd v\u00fdzkum prokazuj\u00edc\u00ed v\u011bt\u0161\u00ed sn\u00ed\u017een\u00ed p\u0159\u00edjmu potravy a t\u011blesn\u00e9 hmotnosti p\u0159i pou\u017eit\u00ed kombinace ne\u017e u kter\u00e9hokoli peptidu samotn\u00e9ho, co\u017e podporuje dal\u0161\u00ed zkoum\u00e1n\u00ed kombinovan\u00e9 signalizace amylinu a inkretinu.<\/p>\n Komplexn\u00ed p\u0159ehled biologie amylinu, farmakologie kagrilintidu a jeho role v metabolick\u00fdch terapi\u00edch nov\u00e9 generace.<\/p>\n Co je CagriTirz Blen<\/strong>d?<\/p>\n CagriTirz Blend kombinuje cagrilintid (5 mg) a tirzepatid (10 mg) v jedin\u00e9 lyofilizovan\u00e9 lahvi\u010dce. Je ur\u010den pro laboratorn\u00ed v\u00fdzkum zkoumaj\u00edc\u00ed komplement\u00e1rn\u00ed metabolick\u00e9 dr\u00e1hy zahrnuj\u00edc\u00ed signalizaci amylinu, GLP-1 a GIP.<\/p>\n Kter\u00e9 peptidy jsou obsa\u017eeny v p\u0159\u00edpravku CagriTirz?<\/strong><\/p>\n Ka\u017ed\u00e1 lahvi\u010dka obsahuje:<\/p>\n Tyto peptidy spole\u010dn\u011b poskytuj\u00ed t\u0159i dopl\u0148kov\u00e9 hormon\u00e1ln\u00ed dr\u00e1hy b\u011b\u017en\u011b zkouman\u00e9 v oblasti regulace chuti k j\u00eddlu, sytosti a metabolick\u00e9ho v\u00fdzkumu.<\/p>\n Pro\u010d se Cagrilintide a Tirzepatide kombinuj\u00ed?<\/strong><\/p>\n Tirzepatid aktivuje receptory GLP-1 a GIP, zat\u00edmco cagrilintid je dlouhodob\u011b p\u016fsob\u00edc\u00ed analog amylinu. Vzhledem k tomu, \u017ee se zam\u011b\u0159uj\u00ed na odli\u0161n\u00e9 fyziologick\u00e9 syst\u00e9my, v\u011bdci tuto kombinaci zkoumaj\u00ed, aby l\u00e9pe porozum\u011bli komplement\u00e1rn\u00ed metabolick\u00e9 signalizaci. Experiment\u00e1ln\u00ed preklinick\u00e9 studie tuto kombinaci rovn\u011b\u017e zkoumaly, a\u010dkoli c\u00edlen\u00e9 klinick\u00e9 studie na lidech je\u0161t\u011b nejsou k dispozici.<\/p>\n Jak\u00e9 oblasti v\u00fdzkumu se b\u011b\u017en\u011b zab\u00fdvaj\u00ed sm\u011bs\u00ed CagriTirz?<\/strong><\/p>\n Na z\u00e1klad\u011b publikovan\u00e9 literatury pro sv\u00e9 jednotliv\u00e9 slo\u017eky je CagriTirz relevantn\u00ed pro v\u00fdzkum zahrnuj\u00edc\u00ed regulaci chuti k j\u00eddlu, signalizaci sytosti, regulaci t\u011blesn\u00e9 hmotnosti, energetickou bilanci, vyprazd\u0148ov\u00e1n\u00ed \u017ealudku, inkretinovou biologii a signalizaci amylinov\u00fdch receptor\u016f.<\/p>\n V \u010dem se CagriTirz li\u0161\u00ed od CagriReta?<\/strong><\/p>\n Ob\u011b sm\u011bsi obsahuj\u00ed kagrilintid, ale CagriTirz jej kombinuje s tirzepatidem a poskytuje aktivitu receptor\u016f pro amylin, GLP-1 a GIP. CagriReta kombinuje kagrilintid s retatrutidem, \u010d\u00edm\u017e p\u0159id\u00e1v\u00e1 agonismus glukagonov\u00e9ho receptoru a roz\u0161i\u0159uje profil receptor\u016f na \u010dty\u0159i metabolick\u00e9 dr\u00e1hy.<\/p>\n Lze aplikovat v\u00fdzkum Cagrilintidu a Tirzepatidu p\u0159\u00edmo na tuto sm\u011bs?<\/strong><\/p>\n Ne zcela. Oba peptidy maj\u00ed podstatnou nez\u00e1vislou klinickou literaturu a povzbudiv\u00e9 preklinick\u00e9 studie zkoumaly jejich kombinaci. V sou\u010dasn\u00e9 dob\u011b v\u0161ak neexistuj\u00ed \u017e\u00e1dn\u00e9 velk\u00e9 klinick\u00e9 studie hodnot\u00edc\u00ed samotnou formulaci CagriTirz, tak\u017ee zji\u0161t\u011bn\u00ed by m\u011bla b\u00fdt interpretov\u00e1na v tomto kontextu.<\/p>\n M\u016f\u017eu si koupit CagriTirz v Evrop\u011b?<\/strong><\/p>\n Ano. Zas\u00edl\u00e1me CagriTirz do v\u011bt\u0161iny evropsk\u00fdch zem\u00ed pomoc\u00ed spolehliv\u00fdch kur\u00fdrn\u00edch slu\u017eeb. Dostupn\u00e9 zp\u016fsoby dopravy a dodac\u00ed lh\u016fty se zobraz\u00ed b\u011bhem dokon\u010dov\u00e1n\u00ed objedn\u00e1vky na z\u00e1klad\u011b va\u0161\u00ed c\u00edlov\u00e9 destinace.<\/p>\n Je tento produkt ur\u010den k lidsk\u00e9mu pou\u017eit\u00ed?<\/strong><\/p>\n Sm\u011bs CagriTirz dod\u00e1van\u00e1 spole\u010dnost\u00ed Life Peptide je ur\u010dena v\u00fdhradn\u011b pro laboratorn\u00ed a analytick\u00fd v\u00fdzkum. Nen\u00ed ur\u010dena k lidsk\u00e9 spot\u0159eb\u011b, diagnostice, l\u00e9\u010db\u011b ani prevenci nemoc\u00ed. Jak\u00e9koli zm\u00ednky o publikovan\u00fdch studi\u00edch shrnuj\u00ed aktu\u00e1ln\u00ed v\u011bdeckou literaturu t\u00fdkaj\u00edc\u00ed se jednotliv\u00fdch peptidov\u00fdch slo\u017eek, nikoli zam\u00fd\u0161len\u00e9ho pou\u017eit\u00ed kombinovan\u00e9 sm\u011bsi.<\/p>\n Kagrilintid \/ tirzepatid integruje signalizaci receptoru pro amylin s du\u00e1ln\u00edm inkretinov\u00fdm agonismem (GLP-1 a GIP) a vytv\u00e1\u0159\u00ed tak multihormon\u00e1ln\u00ed metabolick\u00fd v\u00fdzkumn\u00fd r\u00e1mec. Tirzepatid<\/a> \u2014 du\u00e1ln\u00ed agonista inkretin\u016f (GLP-1\/GIP) Tato sm\u011bs je obzvl\u00e1\u0161t\u011b relevantn\u00ed ve studi\u00edch zam\u011b\u0159en\u00fdch na v\u00edcevrstv\u00e9 endokrinn\u00ed signalizace a kombinovanou interakci dr\u00e1hy sytosti a inkretin\u016f. POZN\u00c1MKA<\/strong>Toto je pouze pro vzd\u011bl\u00e1vac\u00ed \u00fa\u010dely a nep\u0159edstavuje l\u00e9ka\u0159skou radu.<\/p>\n Z\u0159eknut\u00ed se odpov\u011bdnosti<\/strong> CagriTirz Blend 15 mg je v\u00fdzkumn\u00e1 metabolick\u00e1 peptidov\u00e1 formulace kombinuj\u00edc\u00ed Cagrilintid (5 mg) a Tirzepatid (10 mg) v jedn\u00e9 lyofilizovan\u00e9 lahvi\u010dce. Je navr\u017eena pro laboratorn\u00ed v\u00fdzkum a kombinuje signalizaci amylinu s du\u00e1ln\u00edm agonismem receptor\u016f GLP-1 a GIP, \u010d\u00edm\u017e spojuje t\u0159i dopl\u0148uj\u00edc\u00ed se metabolick\u00e9 dr\u00e1hy.<\/p>\n ||<\/p>\n \u010cistota \u226598% | N\u00e1kup v Evrop\u011b s dopravou od 5 \u20ac | Mo\u017enost volby dopravy zdarma | P\u0159ij\u00edm\u00e1me platby kartou<\/p>","protected":false},"featured_media":1049,"template":"","meta":[],"product_brand":[],"product_cat":[19],"product_tag":[152,257,317,248,139,247,153,258,252,246,316],"class_list":["post-1063","product","type-product","status-publish","has-post-thumbnail","product_cat-metabolic-research-peptides","product_tag-amylin-analogue","product_tag-appetite-regulation","product_tag-dual-agonists","product_tag-energy-balance","product_tag-glp-1-research","product_tag-metabolic-peptide","product_tag-metabolic-research","product_tag-obesity-peptide","product_tag-obesity-research","product_tag-weight-loss-peptide","product_tag-weight-management-research","first","instock","taxable","shipping-taxable","purchasable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/product\/1063","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/media\/1049"}],"wp:attachment":[{"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/media?parent=1063"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/product_brand?post=1063"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/product_cat?post=1063"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/product_tag?post=1063"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nPro\u010d na CagriTirz z\u00e1le\u017e\u00ed v metabolick\u00e9m v\u00fdzkumu<\/strong><\/h4>\n
\n
\n
\nDv\u011b slo\u017eky CagriTirz<\/strong><\/h4>\n
Pro\u010d v\u011bdci kombinuj\u00ed cagrilintid s tirzepatidem<\/strong><\/h4>\n
Lidsk\u00fd a preklinick\u00fd v\u00fdzkum<\/strong><\/h4>\n
\n
\nV \u010dem se CagriTirz li\u0161\u00ed od jin\u00fdch metabolick\u00fdch sm\u011bs\u00ed<\/strong><\/h4>\n
\n
\n
\n
Publikovan\u00e1 bezpe\u010dnostn\u00ed opat\u0159en\u00ed<\/strong><\/h4>\n
\nVlastnosti produktu<\/strong><\/h4>\n
\nPou\u017eit\u00ed omezen\u00e9: nen\u00ed ur\u010deno k lidsk\u00e9 spot\u0159eb\u011b; pro l\u00e9ka\u0159sk\u00e9, veterin\u00e1rn\u00ed ani kosmetick\u00e9 pou\u017eit\u00ed
\nVyrobeno v za\u0159\u00edzen\u00edch spl\u0148uj\u00edc\u00edch spr\u00e1vnou v\u00fdrobn\u00ed praxi (GMP) za p\u0159\u00edsn\u00fdch protokol\u016f kontroly kvality.
\nKa\u017ed\u00e1 \u0161ar\u017ee je po v\u00fdrob\u011b pe\u010dliv\u011b laboratorn\u011b testov\u00e1na (Certifik\u00e1t o anal\u00fdze najdete pod obr\u00e1zky produkt\u016f).
\nLyofilizov\u00e1no (su\u0161eno mrazem) pro maxim\u00e1ln\u00ed stabilitu a prodlou\u017eenou trvanlivost.
\nUzav\u0159eno ve steriln\u00edch lahvi\u010dk\u00e1ch, p\u0159ipraveno k rekonstituci.
\n\u010cistota: \u2265 98% (HPLC)
\nVzhled: b\u00edl\u00fd lyofilizovan\u00fd pr\u00e1\u0161ek
\nSlo\u017een\u00ed: Cagrilintid 5 mg + Tirzepatid 10 mg
\nMolekul\u00e1rn\u00ed vzorec Cagrilintide \/ Tirzepatide: C194<\/sub>H312<\/sub>N54<\/sub>O59<\/sub> S2<\/sub> \/ C225<\/sub>H348<\/sub>N48<\/sub>O59<\/sub>
\nMolekulov\u00e1 hmotnost Cagrilintid \/ Tirzepatid: 4409,01 \/ 4813,45
\nSekvence Cagrilintid: {diacid-C20-\u03b3-Glu} KCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTP-NH2
\nSekvence Tirzepatidu: Y{Aib}EGTFTSDYSI{Aib}LDKIAQ-K{diacid-C20-\u03b3-Glu-(AEEA)2}-AFVQWLIAGGPSSGAPPPS-NH2<\/p>\nRekonstituce a manipulace<\/strong><\/h4>\n
\nKl\u00ed\u010dov\u00e9 publikovan\u00e9 studie<\/strong><\/h4>\n
\n
\n
\n
\n
\n\u010casto kladen\u00e9 ot\u00e1zky<\/strong><\/h4>\n
\n
\nSouvisej\u00edc\u00ed v\u00fdzkumn\u00fd kontext<\/strong><\/h4>\n
\nV\u00fdzkumn\u00edci porovn\u00e1vaj\u00edc\u00ed hloubku signalizace nap\u0159\u00ed\u010d slou\u010deninami mohou rovn\u011b\u017e zkoumat:<\/p>\n
\nKagrilintid<\/a> \u2014 analog amylinu
\nRetatrutid<\/a> \u2014 trojit\u00fd receptorov\u00fd agonista
\nSemaglutid<\/a> \u2014 jednocestn\u00fd agonista GLP-1<\/p>\n
\nPro dal\u0161\u00ed kontext viz Pr\u016fvodce v\u00fdzkumem metabolismu GLP-1<\/a> a souvisej\u00edc\u00edch slou\u010denin v r\u00e1mci Metabolick\u00fd v\u00fdzkum<\/a>.<\/p>\n
\nTento produkt je prod\u00e1v\u00e1n pouze pro v\u00fdzkumn\u00e9 \u00fa\u010dely. Nen\u00ed ur\u010den k diagnostice, l\u00e9\u010db\u011b, vyl\u00e9\u010den\u00ed nebo prevenci jak\u00fdchkoli onemocn\u011bn\u00ed. Kupuj\u00edc\u00ed p\u0159eb\u00edr\u00e1 plnou odpov\u011bdnost za \u0159\u00e1dnou manipulaci a pou\u017eit\u00ed.<\/p>","protected":false},"excerpt":{"rendered":"